About Index Trending news
Analyze
Pricing
Editas Medicine

Editas Medicine

Work at Editas Medicine? Add yourself to this profile

Editas Medicine

Unlocking the promise of genome editing to deliver life-changing medicines

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding Show all
IPO
$94,000,000
Venture capital (Series B)
$120,000,000
Khosla Ventures, Google Ventures, Alexandria Venture, +9
Employees

Team size

10+
Locations
HQ
$94,000,000 IPO
GeekWire , Wired

Editas Medicine raises $94M in first gene-editing IPO, and then stock price rises

Science Stock markets
Xconomy

As Markets and Controversies Swirl, Editas Aims For $100M CRISPR IPO

Science Health
GeekWire

Gates-backed Editas Medicine files for IPO, marking CRISPR gene-editing milestone

Science Funding